Paper508161
Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.
Lassmann H and 1 other. Arch Neurol, 1979. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Papers, record 508161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/508161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Encephalomyelitis, Autoimmune, Experimental | Major topic |
| Multiple Sclerosis | Major topic |
| Animals | |
| Demyelinating Diseases | |
| Guinea Pigs |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31507583 | Obesity Promotes EAE Through IL-6 and CCL-2-Mediated T Cells Infiltration. | Front Immunol | 2019 | https://conductscience.org/library/papers/31507583 | PubMed |
| 27766432 | Multiple sclerosis: experimental models and reality. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/27766432 | PubMed |
| 25063874 | Thiamine deficiency promotes T cell infiltration in experimental autoimmune encephalomyelitis: the involvement of CCL2. | J Immunol | 2014 | https://conductscience.org/library/papers/25063874 | PubMed |
| 23997981 | S-Nitrosoglutathione administration ameliorates cauda equina compression injury in rats. | Neurosci Med | 2012 | https://conductscience.org/library/papers/23997981 | PubMed |
| 23188522 | Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. | J Neuroimmune Pharmacol | 2013 | https://conductscience.org/library/papers/23188522 | PubMed |
| 21647172 | SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. | Immunol Cell Biol | 2012 | https://conductscience.org/library/papers/21647172 | PubMed |
| 18722816 | Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. | Clin Immunol | 2008 | https://conductscience.org/library/papers/18722816 | PubMed |
| 18272282 | Disseminated encephalomyelitis in children. | Clin Neurol Neurosurg | 2008 | https://conductscience.org/library/papers/18272282 | PubMed |
| 17655940 | MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. | J Neuroimmunol | 2007 | https://conductscience.org/library/papers/17655940 | PubMed |
| 15229242 | A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. | J Neurosci | 2004 | https://conductscience.org/library/papers/15229242 | PubMed |
| 9736016 | The fate of T cells in the brain: veni, vidi, vici and veni, mori. | Am J Pathol | 1998 | https://conductscience.org/library/papers/9736016 | PubMed |
| 9625765 | Endogenous myelin basic protein inactivates the high avidity T cell repertoire. | J Exp Med | 1998 | https://conductscience.org/library/papers/9625765 | PubMed |
| 8742985 | Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques. | Ital J Neurol Sci | 1996 | https://conductscience.org/library/papers/8742985 | PubMed |
| 8293181 | Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis. | Brain Pathol | 1993 | https://conductscience.org/library/papers/8293181 | PubMed |
| 7445973 | Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis. | Acta Neuropathol | 1980 | https://conductscience.org/library/papers/7445973 | PubMed |
| 7331770 | In vivo effect of sera from animals with chronic relapsing experimental allergic encephalomyelitis on central and peripheral myelin. | Acta Neuropathol | 1981 | https://conductscience.org/library/papers/7331770 | PubMed |
| 6766340 | Suppression of multiple sclerosis. | Br Med J | 1980 | https://conductscience.org/library/papers/6766340 | PubMed |
| 6730912 | Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system. | Acta Neuropathol | 1984 | https://conductscience.org/library/papers/6730912 | PubMed |
| 6192222 | Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis. | J Neurol | 1983 | https://conductscience.org/library/papers/6192222 | PubMed |
| 6086712 | Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. | J Neuroimmunol | 1984 | https://conductscience.org/library/papers/6086712 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/508161
GET https://conductscience.org/api/papers/v1/508161/cited_by?page=2